Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
ORNBV
NASDAQ Helsinki
Biotechnology & Pharmaceuticals
Health Care
Orion operates in the pharmaceutical industry. The company conducts research and development of human and veterinary drugs, where the main focus is on diseases that affect the nervous system, as well as oncology and respiratory diseases. Today, the company's products are found on a global level, with the largest presence in the Nordic region and the rest of Europe. The company's head office is located in Espoo, Finland.
Read more
Analyst
Revenue B
EBIT-% (adj.)
EPS (adj.)
Dividend %
Half year dividend
Interim report Q3'26
Annual report '26
Don't miss out - create an account and get all the possible benefits
